| |
 |
 |
AHHJ
The American Heart Hospital Journal® |
|
|
AJGC
The American Journal of Geriatric Cardiology |
|
|
CHF
Congestive Heart Failure® |
|
|
JCMS
Journal of the CardioMetabolic Syndrome |
|
|
JCH
The Journal of Clinical Hypertension® |
|
| |
|
PCVN
Progress in Cardiovascular Nursing® |
|
|
SKINmed®
Dermatology for the Clinician |
|
|
| |
|
|
| |
| |
| |
|
|
|
|
| SUPPLEMENTS TO LE JACQ JOURNALS |
|
| |
|
|
| The Journal of Clinical Hypertension® • August 2005 • Supplement 2 |
| "The Perindopril Collection: Commentaries and Essential Papers" |
| Supported through an unrestricted educational grant from CV Therapeutics. |
|
|
|
|
|
| The Journal of Clinical Hypertension® • April 2005 • Supplement 1 |
| "Calcium Channel Blockers: A More Expansive Treatment Role" |
| Supported through an unrestricted educational grant from Reliant Pharmaceuticals, Inc. |
|
|
|
|
|
| The Journal of Clinical Hypertension® • November 2004 • Supplement 3 |
| "Microalbuminuria" |
| Supported through an unrestricted educational grant from AusAm Biotechnologies, Inc. |
|
 |
|
|
| The Journal of Clinical Hypertension® • October 2004 • Supplement 2 |
| "Update on the Management of Hypertension" |
| Supported through an unrestricted educational grant from Merck US Human Health. |
|
|
|
|
| Congestive Heart Failure® • September/October 2004 • Supplement 3 |
| "BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases" |
| Supported through unrestricted educational grants from Bayer HealthCare, Diagnostics Division and BIOSITE, Inc. |
|
|
|
|
|
| The American Heart Hospital Journal® • Fall 2004 • Supplement 1 |
| "Cardiology in Practice: New Ideas in Transition" |
| This supplement is based on presentations made at a symposium that was part of the Dayton Heart Hospital Distinguished Lecture series, June 19, 2004. Supported through an unrestricted educational grant from AstraZeneca, LP. |
|
|
|
|
| The American Journal of Geriatric Cardiology • May/June 2004 • Supplement 1 |
| "Hyperlipidemia in the Elderly" |
| Supported through an unrestricted educational grant from Bristol-Myers Squibb. |
|
|
|
|
| The Journal of Clinical Hypertension® • April 2004 • Supplement 1 |
| "Managing Cardiovascular Disease in African Americans: Emerging Strategies for Optimizing Care" |
| This supplement is based on a roundtable meeting held April 24–25, 2003, in Washington, DC. The meeting and publication of these proceedings were supported by an unrestricted educational grant from GlaxoSmithKline, Inc. Editorial support was provided by ACCEL Medical Education. |
|
|
|
|
| Congestive Heart Failure® • March/April 2004 • Supplement 2 |
| "Impedance Cardiography: Clinical Applications in Heart Failure" |
| Provided as an educational service from CardioDynamics, The ICG Company. |
|
|
|
|
|
| Congestive Heart Failure® • January/February 2004 • Supplement 1 |
| "B-Type Natriuretic Peptide: The Level and the Drug—Partners in the Diagnosis and Management of Congestive Heart Failure" |
| Supported through unrestricted educational grants from Scios, Inc., Bayer HealthCare, LLC, and Biosite, Inc. |
|
|
|
|
| The Journal of Clinical Hypertension® • November/December 2003 • Supplement 4 |
| "Update on the Management of Hypertension" |
| Supported through an unrestricted educational grant from Merck US Human Health. |
|
|
|
|
| Congestive Heart Failure® • November/December 2003 • Supplement 2 |
| "Safety and Efficacy of Therapeutically Equivalent Doses of Sustained-Release Formulations of Isradipine and Felodipine" |
| Supported through an unrestricted educational grant from Reliant Pharmaceuticals, Inc. |
|
|
|
|
| Congestive Heart Failure® • September/October 2003 • Supplement 1 |
| "Management of Acute Decompensated Heart Failure in the Emergency Department" |
| Reprinted with permission of The Cleveland Clinic Center for Continuing Education and Unitech Communications, Inc, a subsidary of The Cleveland Clinic. This project was partially sponsored by an unrestricted educational grant from Scios, Inc. |
|
|
|
|
| The Journal of Clinical Hypertension® • July/August 2003 • Supplement 3 |
| "Achieving Blood Pressure Goals: Is Fixed-Dose Combination Therapy the Answer?" |
| Supported through an unrestricted educational grant from Novartis Pharmaceuticals Corporation. |
|
|
|
|
| The Journal of Clinical Hypertension® • May/June 2003 • Supplement 2 |
| "Uncontrolled Hypertension: Whose Problem Is It?" |
| Supported through an unrestricted educational grant from Novartis Pharmaceuticals Corporation. |
|
|
|
|
| The Journal of Clinical Hypertension® • January/February 2003 • Supplement 1 |
| "Management of Hypertension and Cardiovascular Risk Factors in African Americans" |
| Supported through an unrestricted educational grant from Wyeth Pharmaceuticals and King Pharmaceuticals. |
|
|
|
|
| The Journal of Clinical Hypertension® • November/December 2002 • Supplement 2 |
| "Update on The Management of Hypertension" |
| Supported through an unrestricted educational grant from Merck US Human Health. |
|
|
|
|
| The Journal of Clinical Hypertension® • July/August 2002 • Supplement 1 |
| "Importance of Consistent 24-Hour Blood Pressure Control" |
| Based on selected proceedings of a satellite symposium at the 18th International Society of Hypertension meeting and a closed roundtable meeting on the importance of control of systolic and diastolic hypertension throughout the 24-hour dosing interval. Supported through an unrestricted educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
